Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03033914
Title A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 United States Details
Hackensack Meridian Health Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
BC Cancer (Data Collection Only) Vancouver V5Z4E6 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field